Endurant Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,185
| Closed | -$4.4M | – | 36 |
|
|
2023
Q1 | $4.4M | Buy |
9,185
+5,292
| +136% | +$2.53M | 2.26% | 14 |
|
|
2022
Q4 | $1.64M | Sell |
3,893
-3,091
| -44% | -$1.3M | 0.66% | 27 |
|
|
2022
Q3 | $2.91M | Sell |
6,984
-9,044
| -56% | -$3.77M | 0.95% | 27 |
|
|
2022
Q2 | $7.93M | Sell |
16,028
-1,123
| -7% | -$556K | 2.78% | 12 |
|
|
2022
Q1 | $9.66M | Buy |
17,151
+2,612
| +18% | +$1.47M | 2.54% | 11 |
|
|
2021
Q4 | $11M | Sell |
14,539
-3,733
| -20% | -$2.82M | 2.65% | 10 |
|
|
2021
Q3 | $13.6M | Buy |
18,272
+6,452
| +55% | +$4.81M | 3.1% | 6 |
|
|
2021
Q2 | $7.62M | Sell |
11,820
-2,964
| -20% | -$1.91M | 2.09% | 16 |
|
|
2021
Q1 | $8.44M | Buy |
+14,784
| New | +$8.44M | 2.2% | 18 |
|
|
2020
Q4 | – | Sell |
-3,916
| Closed | -$2.02M | – | 58 |
|
|
2020
Q3 | $2.02M | Buy |
3,916
+411
| +12% | +$212K | 0.6% | 41 |
|
|
2020
Q2 | $1.58M | Buy |
+3,505
| New | +$1.58M | 0.09% | 40 |
|
|
2019
Q4 | – | Sell |
-6,910
| Closed | -$2.3M | – | 55 |
|
|
2019
Q3 | $2.3M | Buy |
6,910
+3,175
| +85% | +$1.06M | 0.83% | 24 |
|
|
2019
Q2 | $1.17M | Buy |
+3,735
| New | +$1.17M | 0.46% | 42 |
|